nodes	percent_of_prediction	percent_of_DWPC	metapath
Progabide—GABBR1—prostate gland—prostate cancer	0.091	0.264	CbGeAlD
Progabide—GABBR1—seminal vesicle—prostate cancer	0.077	0.223	CbGeAlD
Progabide—GABBR1—urethra—prostate cancer	0.0609	0.177	CbGeAlD
Progabide—GABBR1—bone marrow—prostate cancer	0.0469	0.136	CbGeAlD
Progabide—GABBR1—testis—prostate cancer	0.0401	0.116	CbGeAlD
Progabide—Bezafibrate—PPARA—prostate cancer	0.0351	0.654	CrCbGaD
Progabide—GABBR1—lymph node—prostate cancer	0.0291	0.0842	CbGeAlD
Progabide—Bezafibrate—CYP1A1—prostate cancer	0.0113	0.211	CrCbGaD
Progabide—Bezafibrate—CYP3A4—prostate cancer	0.00724	0.135	CrCbGaD
Progabide—GABBR1—G alpha (i) signalling events—ANXA1—prostate cancer	0.00398	0.00662	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—PENK—prostate cancer	0.00398	0.00662	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—RGS17—prostate cancer	0.00392	0.00651	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—ACHE—prostate cancer	0.00378	0.00628	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RRAS—prostate cancer	0.00372	0.00619	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—CXCL12—prostate cancer	0.00364	0.00606	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—PRKACB—prostate cancer	0.00361	0.00601	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—RGS17—prostate cancer	0.00356	0.00591	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—RLN2—prostate cancer	0.00349	0.0058	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—KCNN3—prostate cancer	0.00347	0.00577	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—COMT—prostate cancer	0.00343	0.00571	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GNRH1—prostate cancer	0.00338	0.00563	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GRP—prostate cancer	0.00328	0.00545	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—LPAR1—prostate cancer	0.00328	0.00545	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PLXNB1—prostate cancer	0.00319	0.00531	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—CX3CL1—prostate cancer	0.00318	0.00529	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HSP90B1—prostate cancer	0.00317	0.00528	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—RLN2—prostate cancer	0.00317	0.00527	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRPR—prostate cancer	0.00307	0.00511	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—GNG5—prostate cancer	0.00294	0.0049	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PLXNB1—prostate cancer	0.0029	0.00482	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB2—prostate cancer	0.00282	0.00469	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—RRAS—prostate cancer	0.0028	0.00465	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRPR—prostate cancer	0.00279	0.00464	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—COMT—prostate cancer	0.00263	0.00437	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—NCOA2—prostate cancer	0.00261	0.00434	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—PTHLH—prostate cancer	0.00256	0.00426	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GNG5—prostate cancer	0.00256	0.00426	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—MC2R—prostate cancer	0.00252	0.0042	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—OR51E2—prostate cancer	0.00247	0.00411	CbGpPWpGaD
Progabide—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00244	0.00406	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—ANXA1—prostate cancer	0.00241	0.00401	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—WNT4—prostate cancer	0.0024	0.00399	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—MC2R—prostate cancer	0.00229	0.00381	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—BMPR1B—prostate cancer	0.00226	0.00376	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—CALCA—prostate cancer	0.00226	0.00375	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PENK—prostate cancer	0.00225	0.00374	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—CXCL12—prostate cancer	0.00221	0.00367	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—NCOA1—prostate cancer	0.0022	0.00366	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKACB—prostate cancer	0.00218	0.00363	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—RRAS—prostate cancer	0.00214	0.00357	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—PLCB2—prostate cancer	0.00212	0.00353	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RGS17—prostate cancer	0.0021	0.00349	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—RXRA—prostate cancer	0.00209	0.00348	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PENK—prostate cancer	0.00204	0.0034	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—SLC22A1—prostate cancer	0.00202	0.00337	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00201	0.00334	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—PRKACB—prostate cancer	0.002	0.00333	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—GNG5—prostate cancer	0.00193	0.0032	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—VIP—prostate cancer	0.00191	0.00318	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GNRH1—prostate cancer	0.00191	0.00318	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—ADRB2—prostate cancer	0.00189	0.00315	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RLN2—prostate cancer	0.00187	0.00311	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL1RN—prostate cancer	0.00186	0.0031	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—LPAR1—prostate cancer	0.00185	0.00308	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GRP—prostate cancer	0.00185	0.00308	CbGpPWpGaD
Progabide—GABBR1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.00184	0.00305	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PLCB2—prostate cancer	0.00183	0.00305	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CTBP2—prostate cancer	0.00179	0.00297	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HSD17B1—prostate cancer	0.00179	0.00297	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PDE4D—prostate cancer	0.00175	0.00291	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GNRH1—prostate cancer	0.00174	0.00289	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—VIP—prostate cancer	0.00174	0.00289	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—ESR2—prostate cancer	0.00173	0.00287	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—ACHE—prostate cancer	0.00172	0.00285	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—TH—prostate cancer	0.00171	0.00285	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PLXNB1—prostate cancer	0.00171	0.00285	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—LPAR1—prostate cancer	0.00168	0.0028	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GRP—prostate cancer	0.00168	0.0028	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PLCB2—prostate cancer	0.00167	0.00277	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—GNG5—prostate cancer	0.00166	0.00277	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRPR—prostate cancer	0.00165	0.00274	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—PRKACB—prostate cancer	0.00164	0.00273	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—CX3CL1—prostate cancer	0.00163	0.00272	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—PLCB2—prostate cancer	0.00163	0.0027	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—EGR1—prostate cancer	0.00162	0.00269	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—PPARA—prostate cancer	0.0016	0.00266	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL17RD—prostate cancer	0.00159	0.00265	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PDE4D—prostate cancer	0.00159	0.00264	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC39A1—prostate cancer	0.00159	0.00264	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—SLC22A1—prostate cancer	0.00155	0.00258	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—GJA1—prostate cancer	0.00154	0.00256	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—AR—prostate cancer	0.00153	0.00254	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—GNG5—prostate cancer	0.00151	0.00251	CbGpPWpGaD
Progabide—GABBR1—G alpha (i) signalling events—CXCL8—prostate cancer	0.00151	0.00251	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—GNG5—prostate cancer	0.00148	0.00245	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PTHLH—prostate cancer	0.00145	0.00241	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—JUP—prostate cancer	0.00142	0.00236	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—WNT4—prostate cancer	0.00142	0.00236	CbGpPWpGaD
Progabide—GABBR1—Neuronal System—MDM2—prostate cancer	0.00141	0.00234	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ANXA1—prostate cancer	0.00136	0.00227	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—RALBP1—prostate cancer	0.00135	0.00225	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MC2R—prostate cancer	0.00135	0.00225	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL10—prostate cancer	0.00133	0.00222	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PTHLH—prostate cancer	0.00132	0.00219	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—ACHE—prostate cancer	0.00131	0.00219	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—CYP7B1—prostate cancer	0.00129	0.00215	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PRKACB—prostate cancer	0.00129	0.00214	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—CALCA—prostate cancer	0.00128	0.00212	CbGpPWpGaD
Progabide—GABRA1—Orphan transporters—CREBBP—prostate cancer	0.00127	0.00211	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC12A2—prostate cancer	0.00126	0.0021	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC26A4—prostate cancer	0.00126	0.0021	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—PRKACB—prostate cancer	0.00126	0.00209	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PPP3CA—prostate cancer	0.00126	0.00209	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—CXCL12—prostate cancer	0.00125	0.00207	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ANXA1—prostate cancer	0.00124	0.00206	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—NR3C1—prostate cancer	0.00123	0.00205	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PENK—prostate cancer	0.00121	0.00201	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—COMT—prostate cancer	0.00119	0.00199	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—CALCA—prostate cancer	0.00116	0.00193	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GHR—prostate cancer	0.00115	0.00191	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PRKCQ—prostate cancer	0.00114	0.00189	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—CXCL12—prostate cancer	0.00113	0.00188	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—HIF1A—prostate cancer	0.00112	0.00187	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NRP1—prostate cancer	0.0011	0.00183	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ADRB2—prostate cancer	0.00107	0.00178	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—VAV3—prostate cancer	0.00104	0.00173	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PRKCQ—prostate cancer	0.00103	0.00172	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VIP—prostate cancer	0.00103	0.00171	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GNRH1—prostate cancer	0.00103	0.00171	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC22A3—prostate cancer	0.00102	0.0017	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—ITPR1—prostate cancer	0.00101	0.00168	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRP—prostate cancer	0.000994	0.00165	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—LPAR1—prostate cancer	0.000994	0.00165	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PLCB2—prostate cancer	0.000984	0.00164	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—LRP2—prostate cancer	0.000984	0.00164	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ADRB2—prostate cancer	0.000971	0.00161	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CX3CL1—prostate cancer	0.000965	0.0016	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—P4HB—prostate cancer	0.000965	0.0016	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—VAV3—prostate cancer	0.000947	0.00157	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000947	0.00157	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—ABCG5—prostate cancer	0.000944	0.00157	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PDE4D—prostate cancer	0.000938	0.00156	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GRB7—prostate cancer	0.000938	0.00156	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—ITPR1—prostate cancer	0.000918	0.00153	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CREBBP—prostate cancer	0.000918	0.00153	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—COMT—prostate cancer	0.000916	0.00152	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HIST1H4H—prostate cancer	0.000914	0.00152	CbGpPWpGaD
Progabide—GABBR1—GPCR ligand binding—CXCL8—prostate cancer	0.000914	0.00152	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GNG5—prostate cancer	0.000893	0.00148	CbGpPWpGaD
Progabide—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—prostate cancer	0.00085	0.00141	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC22A1—prostate cancer	0.000834	0.00139	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—GNG5—prostate cancer	0.000793	0.00132	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TGFBR1—prostate cancer	0.000778	0.00129	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PTHLH—prostate cancer	0.000778	0.00129	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AKR1C3—prostate cancer	0.000765	0.00127	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PRKACB—prostate cancer	0.000761	0.00127	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—THBS1—prostate cancer	0.000742	0.00123	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PPP3CA—prostate cancer	0.000742	0.00123	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ANXA1—prostate cancer	0.000731	0.00122	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CXCL8—prostate cancer	0.000729	0.00121	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PRKCZ—prostate cancer	0.000718	0.00119	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CG—prostate cancer	0.000701	0.00117	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000698	0.00116	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PARP1—prostate cancer	0.000693	0.00115	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGFR4—prostate cancer	0.000693	0.00115	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CALCA—prostate cancer	0.000685	0.00114	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—PRKACB—prostate cancer	0.000676	0.00112	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000673	0.00112	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CXCL12—prostate cancer	0.000669	0.00111	CbGpPWpGaD
Progabide—GABRA1—Transmission across Chemical Synapses—MDM2—prostate cancer	0.000639	0.00106	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—NCOA2—prostate cancer	0.000638	0.00106	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CG—prostate cancer	0.000637	0.00106	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CASP9—prostate cancer	0.00063	0.00105	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000625	0.00104	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CD—prostate cancer	0.000617	0.00103	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PRKCQ—prostate cancer	0.00061	0.00101	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NGFR—prostate cancer	0.00061	0.00101	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—SLC5A5—prostate cancer	0.000608	0.00101	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAP3K7—prostate cancer	0.000603	0.001	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000592	0.000984	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGF10—prostate cancer	0.00058	0.000964	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ADRB2—prostate cancer	0.000574	0.000954	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—JAK2—prostate cancer	0.000566	0.000941	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—MAP2K1—prostate cancer	0.000564	0.000937	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CD—prostate cancer	0.00056	0.000931	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VAV3—prostate cancer	0.000559	0.00093	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TGFBR2—prostate cancer	0.000551	0.000917	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ITPR1—prostate cancer	0.000543	0.000902	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CB—prostate cancer	0.000537	0.000894	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—NCOA1—prostate cancer	0.000537	0.000893	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IGF1R—prostate cancer	0.000519	0.000863	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—CXCL8—prostate cancer	0.000516	0.000859	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—JAK2—prostate cancer	0.000514	0.000854	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—RXRA—prostate cancer	0.000511	0.00085	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—LPL—prostate cancer	0.000497	0.000827	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—IL2—prostate cancer	0.000494	0.000821	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PDGFRB—prostate cancer	0.000493	0.00082	CbGpPWpGaD
Progabide—GABRA1—Neuronal System—MDM2—prostate cancer	0.00049	0.000814	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CB—prostate cancer	0.000488	0.000811	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ITGB3—prostate cancer	0.00048	0.000799	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—CXCL8—prostate cancer	0.000469	0.00078	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ERBB3—prostate cancer	0.000466	0.000775	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGFR2—prostate cancer	0.000465	0.000774	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL2—prostate cancer	0.000448	0.000745	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TERT—prostate cancer	0.000447	0.000743	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—HIF1A—prostate cancer	0.000427	0.00071	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—LEP—prostate cancer	0.000417	0.000693	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CAV1—prostate cancer	0.000413	0.000687	CbGpPWpGaD
Progabide—GABRA1—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000409	0.000681	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—KDR—prostate cancer	0.000408	0.000679	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ESR1—prostate cancer	0.000398	0.000662	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—PPARA—prostate cancer	0.00039	0.000649	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—BAD—prostate cancer	0.000389	0.000646	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—APC—prostate cancer	0.000376	0.000626	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CG—prostate cancer	0.000376	0.000626	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EGF—prostate cancer	0.000372	0.000618	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IRS1—prostate cancer	0.000372	0.000618	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—GSK3B—prostate cancer	0.000361	0.0006	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—INS—prostate cancer	0.000356	0.000592	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CREBBP—prostate cancer	0.000349	0.00058	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IGF1—prostate cancer	0.000345	0.000573	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—EGFR—prostate cancer	0.000343	0.00057	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MAP2K1—prostate cancer	0.000333	0.000554	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CD—prostate cancer	0.000331	0.00055	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—PIK3CA—prostate cancer	0.000328	0.000545	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SERPINE1—prostate cancer	0.000327	0.000544	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—KRAS—prostate cancer	0.000324	0.000538	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—FGF2—prostate cancer	0.000317	0.000527	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—NOS3—prostate cancer	0.000312	0.000519	CbGpPWpGaD
Progabide—GABRA1—Transmembrane transport of small molecules—CREBBP—prostate cancer	0.00031	0.000515	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—JAK2—prostate cancer	0.000304	0.000505	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—PIK3CA—prostate cancer	0.000298	0.000495	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MDM2—prostate cancer	0.000296	0.000493	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—ERBB2—prostate cancer	0.000292	0.000486	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CB—prostate cancer	0.000288	0.000479	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CXCL8—prostate cancer	0.000277	0.000461	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CDKN1B—prostate cancer	0.000271	0.00045	CbGpPWpGaD
Progabide—GABBR1—GPCR downstream signaling—AKT1—prostate cancer	0.000268	0.000445	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CASP3—prostate cancer	0.000265	0.000441	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL2—prostate cancer	0.000265	0.00044	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—IL6—prostate cancer	0.000263	0.000438	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CCND1—prostate cancer	0.000258	0.000429	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CTNNB1—prostate cancer	0.000256	0.000425	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MMP9—prostate cancer	0.000251	0.000417	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—CDKN1A—prostate cancer	0.00025	0.000415	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PTEN—prostate cancer	0.000249	0.000414	CbGpPWpGaD
Progabide—GABBR1—Signaling by GPCR—AKT1—prostate cancer	0.000243	0.000404	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EP300—prostate cancer	0.000238	0.000395	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—SRC—prostate cancer	0.000231	0.000384	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—VEGFA—prostate cancer	0.000225	0.000374	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—STAT3—prostate cancer	0.000223	0.00037	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—MYC—prostate cancer	0.000207	0.000344	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TGFB1—prostate cancer	0.000207	0.000343	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—EGFR—prostate cancer	0.000203	0.000337	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—KRAS—prostate cancer	0.000191	0.000318	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—PIK3CA—prostate cancer	0.000176	0.000292	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—TP53—prostate cancer	0.00017	0.000283	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—IL6—prostate cancer	0.000156	0.000259	CbGpPWpGaD
Progabide—GABBR1—Signaling Pathways—AKT1—prostate cancer	0.000144	0.000239	CbGpPWpGaD
